載入...
Identification of novel drugs to target dormant micrometastases
BACKGROUND: Cancer-specific survival has changed remarkably little over the past half century, mainly because metastases that are occult at diagnosis and generally resistant to chemotherapy subsequently develop months, years or even decades following definitive therapy. Targeting the dormant microme...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4434572/ https://ncbi.nlm.nih.gov/pubmed/25971923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1409-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|